Showing 1 - 10 of 136
Oped, Editorial, Published on 27/02/2026
» A music video released by the State Audit Office (SAO) came at just the right time. Without this house track, the harrowing collapse of its under-construction building might have begun to fade from public attention.
Nonthawat Phakham, Published on 28/01/2026
» Have you ever felt confused buying fabric softener or detergent in Thailand? I have. Choosing these products is no longer just about scent. They now offer features like UV protection, night-dry and indoor-dry formulas, quick or expert wash options, fast-wash, anti–colour-transfer technology and multiple scent variations for each formula.
Oped, Kavi Chongkittavorn, Published on 27/01/2026
» US President Donald Trump's invitation to Thailand to join the Board of Peace (BOP) has elicited three distinct responses. The first two are succinct and clear in their rationale. The third, however, is more nuanced -- and notable for its ambivalence.
News, Ron Bousso, Published on 30/10/2025
» European governments seeking to expand offshore wind power are increasingly wary of Chinese companies' involvement. Countering China's dominance will be time-consuming and expensive, but political pressure and national security concerns may give the region little choice.
Oped, Editorial, Published on 17/10/2025
» The mass reshuffle involving 45 senior officials under the Interior Ministry, including provincial governors and department heads, is causing a stir.
Oped, George G van der Meulen & Chamniern Vorratnchaiphan, Published on 16/09/2025
» Thailand has faced floods for more than a century. Some years are worse than others, but the pattern is consistent. The catastrophic 2011 floods remain the most painful reminder: according to the World Bank, they caused US$46.5 billion (1.5 trillion baht) in economic losses, displaced 13 million people, and claimed approximately 800 lives. Much of the country's industrial heartland was submerged for months, severely impacting global supply chains.
Oped, Emmanuel Guerin & Bernice Lee, Published on 12/08/2025
» Earlier this year, the Chinese firm CATL, the world's largest battery-maker, unveiled an electric-vehicle (EV) battery capable of delivering a remarkable 520 kilometres (323 miles) of driving range after just five minutes of charging. The announcement came a month after BYD, China's leading EV manufacturer, launched its own ultra-fast charging system. In solar, too, the numbers are staggering: Chinese firms can now produce over 1,200 gigawatts of solar panels annually.
Oped, Lili Yan Ing, Published on 23/07/2025
» Be careful what you wish for, lest it come true. That ancient proverb comes to mind when considering the eagerness of America's trade partners around the world to negotiate deals with US President Donald Trump's administration. Four countries already have, with Indonesia the latest to do so -- and possibly the first to regret it.
News, Manishi Raychaudhuri, Published on 20/05/2025
» As the United States and Europe have sought to loosen their economic ties with China in recent years, Beijing has focused on expanding its export markets across the "Global South", particularly in Southeast Asia. But this could create significant economic risks as the region's manufacturers struggle to compete. Regardless of the contours of any eventual US-China trade deal, Beijing's exports to America seem destined to continue falling, as do those to the European Union. The bloc has been seeking to "de-risk" from Chinese imports and supply chains, particularly when it comes to electric vehicles, batteries and solar power equipment.
Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.